Abbott Laboratories
ABT
Ранг среди акций
#103
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Цена акции
$104.70
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$181.16B
Изменение (1 день)
-0.09%
Изменение (1 год)
-18.26%
Страна
US
Торговля Abbott Laboratories (ABT)
Категория
Healthcare
EPS для Abbott Laboratories (ABT)
EPS по состоянию на December 2025 TTM: $3.74
Согласно последним финансовым отчетам и цене акций Abbott Laboratories, текущий EPS компании (TTM) составляет $3.74. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Abbott Laboratories с 2026 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $3.59 | -4.01% |
IE
|
|
| $9.73 | 160.16% |
US
|
|
| $2.48 | -33.69% |
US
|
|
| - | - |
DE
|
|
| $1.74 | -53.48% |
US
|
